Effects of cyclosporin A on neurological outcome and serum biomarkers in the same setting of spinal cord ischemia model

Annals of Vascular Surgery

Volumn 20, Issue 2, 2006, Pages 243-249

  Ozkisacik, Erdem A ^a   Discigil, Berent ^a   Boga, Mehmet ^a   Gurcun, Ugur ^a   Badak, Muharrem I ^a   Kurtoglu, Tunay ^a   Yenisey, Cigdem ^a   Dikicioglu, Emel ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN A; NEURON SPECIFIC ENOLASE; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; JOHNSON SCALE; LAPAROTOMY; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RATING SCALE; SPINAL CORD ISCHEMIA;

EID: 33646521959     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-006-9022-2     Document Type: Article

References (23)

1. Svensson LG, Crawford ES, Hess KR, et al. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993;17:357-370.
2. Gharagozloo F, Larson J, Dausmann MJ, et al. Spinal cord protection during surgical procedures on the descending thoracic and thoracoabdominal aorta: review of current techniques. Chest 1996;109:799-809.
3. Qayumi AK, Janusz MT, Jamieson WR, et al. Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 1992;104:256-261.
4. Wan IY, Angelini GD, Bryan AJ, et al. Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery. Bur J Cardiothorac Surg 2001;19:203-213.
5. Atzeni F, Sarzi-Puttini P, Capsoni F, et al. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 2003;21:759-762.
6. Morris PJ. Cyclosporine, FK-506 and other drugs in organ transplantation. Curr Opin Immunol 1991;3:748-751.
7. Cheung A, Menkis AH.. Cyclosporine heart transplantation. Transplant Proc 1998;30:1881-1884.
8. Kaminska B, Gaweda-Walerych K, Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants - facts and hypotheses. J Cell Mol Med 2004;8:45-58.
9. Navarro-Gonzalvez JA, Garcia-Benayas C, Arenas J. Semi-automated measurement of nitrate in biological fluids. Clin Chem 1998;44:679-681.
10. Johnson SH, Kraimer JM, Graeber GM.. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits. Stroke 1993;24:1547-1553.
11. Almeida A, Delgado-Esteban M, Bolanos JP, et al. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J Neurochem 2002;81:207-217.
12. Hansson MJ, Persson T, Friberg H, et al. Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria. Brain Res 2003;960:99-111.
13. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911-918.
14. Cunningham RT, Young IS, Winder J, et al. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991;21:497-500.
15. Loy DN, Sroufe AE, Pelt JL, et al. Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta. Neurosurgery 2005;56:391-397.
16. Fischer S, Clauss M, Wiesnet M, et al. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 1999;276:812-820.
17. Marchi N, Rasmussen P, Kapural M, et al. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restor Neurol Neurosci 2003;21:109-121.
18. Sullivan PG, Rabchevsky AG, Hicks RR, et al. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000;101:289-295.
19. Tachibana T, Shiiya N, Kunihara T, et al. Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg 2005;129:123-128.
20. Sato M, Horinouchi T, Sakurai M, et al. Cyclosporin A reduces delayed motor neuron death after spinal cord ischemia in rabbits. Ann Thorac Surg 2003;75:1294-1299.
21. Mobley LW, 3rd, Agrawal SK.. Role of calcineurin in calcium-mediated hypoxic injury to white matter. Spine J 2003;3:11-18.
22. In JH, Lee JE, Lim YG, et al. Regulation and localization of neuronal nitric oxide synthase in the ischemic rabbit spinal cord. Mol Cells 2003;15:406-411.
23. Diaz-Ruiz A, Vergara P, Perez-Severiano F, et al. Cyclosporin A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats. Neurochem Res 2005;30:245-251.